Transcriptional silencing of MGMT gene and increased tumor sensitivity to alkylating drugs was observed in gliomas, colorectal carcinomas, ovarian carcinomas, non-small cell lung carcinomas, head and neck carcinomas, lymphomas, etc. [11,12]. This evidence concerns the gene MGMT and neoplasm.